Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03419260 · ClinicalTrials.gov registry record
Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
A clinical trial of Seizures, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT03419260: Recruiting study of Seizures, sponsored by Children's Hospital of Philadelphia.
NCT03419260 is a study of Seizures that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 2,500 participants, above the 871-participant average among 39 other Seizures trials with a reported enrollment target (187% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03419260, a study of Seizures, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Electrographic seizures are common in critically ill patients leading to increased use of resource-intense continuous EEG monitoring for seizure identification and management. When identified, electrographic seizures are generally treated with anti-seizure medications, but there are very limited data available regarding optimal treatment in terms of the efficacy or safety of specific anti-seizure medications or overall management strategies. This is a single-center prospective observational study. The investigators aim to: (1) track critically ill patients undergoing clinically indicated EEG monitoring and seizure management to identify risk factors for electrographic seizures, (2) create prediction models guiding EEG monitoring resources to the patients at highest risk for seizures, and (3) evaluate our current management strategy in terms of safety.
Primary Outcome
Percentage of subjects who experience electrographic seizures.
Conditions Studied
Interventions
- OTHER Clinically indicated EEG monitoring.
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2027-01-01 |
What NCT03419260 shows while recruiting
NCT03419260 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 871-participant average among 39 other Seizures trials with a reported enrollment target (187% higher).
The record links to 1 condition, with Seizures appearing as the primary indexed condition, and to 1 intervention - of which Clinically indicated EEG monitoring. is the first listed.
NCT03419260 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03419260 about?
NCT03419260 is a clinical study titled "Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children". Electrographic seizures are common in critically ill patients leading to increased use of resource-intense continuous EEG monitoring for seizure identification and management. When identified, electrographic seizures are generally treated with anti-seizure medications, but there are very limited dat...
What is the current status of trial NCT03419260?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2017-03-13. Estimated completion is 2027-01-01.
What conditions does trial NCT03419260 study?
This clinical trial studies the following conditions: Seizures.
What interventions are being tested in trial NCT03419260?
The interventions under investigation include: Clinically indicated EEG monitoring. (OTHER).
Who is sponsoring clinical trial NCT03419260?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03419260 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03419260's enrollment target sits among peer trials
2,500 3rd of 39 higher than 37 of 39 other Seizures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Seizures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Modulating Movement Intention Via Cortical Stimulation
RECRUITING · NA
-
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
RECRUITING · NA
-
Oxygen Toxicity: Mechanisms in Humans
RECRUITING · NA
-
Longitudinal Study of Neurogenetic Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI